Skip to content
Catalyst

PapersPMID:31237183

The serotonin transporter gene-linked polymorphic region (5-HTTLPR) and the sleep-promoting effects of tryptophan: A randomized placebo-controlled crossover study.

Journal of psychopharmacology (Oxford, England)2019The record ↗

findings
2
compound
1
endpoints
2
  1. Finding, moderate evidenceraisesSleep efficiency
  2. Finding, moderate evidencelowersWake after sleep onset (WASO)
Study, every finding
crossover · 98 participants · 7 days
Dose studied, every finding
L-tryptophan 1000 mg/day (two 500 mg capsules) 20 minutes before bedtime, versus placebo capsules (microcrystalline cellulose)
Population, every finding
Healthy adults aged 20 to 30 without sleep disorder or psychiatric diagnosis, homozygous 5-HTTLPR S'/S' (n = 47) and L'/L' (n = 51) carriers analysed together; double-blind placebo-controlled crossover, 1 week each
  • “Linear mixed model analyses with treatment (tryptophan versus placebo) as a single predictor for objective sleep variables revealed a significant increase in sleep efficiency (b = 0.977, t(1027.10) = 3.337, p < 0.001) and a reduction in objective wake after sleep onset (b = −5.188, t(1027.83) = −3.502, p < 0.001) following tryptophan relative to placebo intake.”

Study record

Design
crossover trial
Species
human
Population
Young adults without psychiatric or sleep-disorder diagnosis, homozygous 5-HTTLPR S'/S' (n = 47) or L'/L' (n = 51); oral L-tryptophan 1000 mg/day for 1 week against 1 week of placebo, 20 minutes before bedtime
Participants
98
Comparator
placebo
Duration
7 days
Endpoints measured
16
Declined
this platform holds no node for the endpoint